Coastlands Capital LP → Pyxis Oncology, Inc. PYXS

Stake: — Shares: — Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 4.05

4,886,652 shares short · +4.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $216K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-04	Civik Thomas	director, officer	Award	2,503,050	$3.89	$9.74M

Other 13D/G Filings on Pyxis Oncology, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-02	SCHEDULE 13G/A	GordonMD Global Investments LP	—	—	view →
2026-07-10	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-07-02	SCHEDULE 13G/A	GordonMD Global Investments LP	—	—	view →
2025-04-02	SCHEDULE	Sullivan Lara	11.21%	7,543,007	view →
2023-04-04	SC	Sullivan Lara	—	—	view →

Other Filings by Coastlands Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-07	SCHEDULE 13G	OnKure Therapeutics, Inc.	—	—	view →
2026-07-01	SCHEDULE 13G/A	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-07-01	SCHEDULE 13G/A	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-06-24	SCHEDULE 13G	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-17	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →